Table 5.
Treatment Year 4 (2001 with the Exception of Maryland, 2002)
| |
|
|
Treatment |
Control |
|
|
||
|---|---|---|---|---|---|---|---|---|
| Comparison | Site | Date | Samples | Nymphs (SD) | Samples | Nymphs (SD) | Weight | Effect size |
| 1 | RI | 6/1–7/2/01 | 15 | 25.3 (0.9) | 15 | 52.3 (3.2) | 7.0 | −0.75 |
| 2 | RI | 7/3–7/25/01 | 15 | 19.6 (1.0) | 15 | 44.2 (2.0) | 6.7 | −1.00 |
| 3 | RI | 7/31–8/3/01 | 15 | 14.4 (1.0) | 15 | 27.6 (1.5) | 7.1 | −0.66 |
| 4 | CT | 5/28/01 | 16 | 45 (4) | 13 | 72 (7) | 7.0 | −0.49 |
| 5 | CT | 6/18/01 | 16 | 74 (5) | 14 | 98 (6) | 7.3 | −0.42 |
| 6 | CT | 7/9/01 | 16 | 35 (4) | 14 | 58 (2) | 7.1 | −0.65 |
| 7 | CT | 7/23/01 | 16 | 4 (1) | 14 | 38 (3) | 6.5 | −1.07 |
| 8 | CT | 8/6/01 | 16 | 7 (1) | 14 | 18 (1) | 6.6 | −1.01 |
| 9 | NY | 5/8–8/23/01 | 197 | 164.1 (1.0) | 173 | 398.6 (2.1) | 83.4 | −0.92 |
| 10 | NJ | 5/24–5/25/01 | 25 | 80 (3) | 20 | 95 (4) | 10.9 | −0.43 |
| 11 | NJ | 5/28–5/30/01 | 25 | 82 (3) | 20 | 174 (9) | 10.3 | −0.79 |
| 12 | NJ | 6/1–6/3/01 | 25 | 48 (3) | 20 | 121 (5) | 9.8 | −1.02 |
| 13 | NJ | 6/5–6/8/01 | 25 | 47 (3) | 20 | 150 (9) | 10.1 | −0.89 |
| 14 | MD | 6/4/02 | 15 | 43 (3) | 15 | 175.2 (7.2) | 5.8 | −1.54 |
| 15 | MD | 6/11/02 | 15 | 71 (5) | 15 | 146.0 (6.9) | 6.9 | −0.81 |
| 16 | MD | 6/13/02 | 15 | 60 (5) | 15 | 154.0 (9.1) | 6.9 | −0.84 |
| 17 | MD | 6/18/02 | 15 | 37 (2) | 15 | 195.6 (9.2) | 5.8 | −1.53 |
SD, standard deviation.